Łukasz Joachimiak

Łukasz Joachimiak

Auto-generated profile, based on publicly available information

Łukasz Joachimiak

Institute of Organic Chemistry, Faculty of Chemistry , Lodz University of Technology , Żeromskiego Street 116 , 90-924 Łódź , Poland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ŁJŁukasz Joachimiak
Łukasz Joachimiak
KBKatarzyna M. Błażewska
Katarzyna M. Błażewska

15 August 2016 in Synthesis
Verified
Journal Article
Closed access
PDF file
KBKatarzyna M. Błażewska
Katarzyna M. Błażewska
JGJoanna Gmach
Joanna Gmach
ŁJŁukasz Joachimiak
Łukasz Joachimiak
§ These authors contributed equally. This review summarizes methods of N-functionalization of imidazole and its derivatives through simple aza-Michael addition. Apart from advances in the development of efficient additives applied for this transformation, examples of this reaction’s applicability in the synthesis of biologically relevant molecules are presented. 1 Introduction 2 Method Development for Aza-Michael Addition of Imidazole Analogues­ 2.1 Reactions Promoted by Catalysts 2.2 Aza-Michael Addition on Solid Support 2.3 Reactions Promoted by Base 2.4 Reactions Catalyzed by Enzymes 2.5 Reaction Promoted by Ionic Liquids 2.6 Microwave-, Pressure-, and Ultrasound-Assisted Aza-Michael Addition­ 2.7 Asymmetric Aza-Michael Addition 3. Applications of Aza-Michael Addition 3.1 Addition to Doubly Activated Michael Acceptors; Side Reactions 3.2 Synthesis of Amino Acids Using Aza-Michael Addition 3.3 Domino Transformations Including Aza-Michael Addition 3.4 Application of Aza-Michael Addition in the Synthesis of Biologically­ Relevant Compounds 4 Conclusions

17 October 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AKAleksandra Kaźmierczak
Aleksandra Kaźmierczak
DKDamian Kusy
Damian Kusy
SNSanna P. Niinivehmas
Sanna P. Niinivehmas
JGJoanna Gmach
Joanna Gmach
ŁJŁukasz Joachimiak
Łukasz Joachimiak
KBKatarzyna M. Błażewska
Katarzyna M. Błażewska

1 September 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FCFraser P. Coxon
Fraser P. Coxon
ŁJŁukasz Joachimiak
Łukasz Joachimiak
ANArafath Kaja Najumudeen
Arafath Kaja Najumudeen
GBGeorge Breen
George Breen
JGJoanna Gmach
Joanna Gmach
KBKatarzyna M. Błażewska
Katarzyna M. Błażewska

2 March 2018 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
ŁJŁukasz Joachimiak
Łukasz Joachimiak
AMAleksandra Marchwicka
Aleksandra Marchwicka
EGEdyta Gendaszewska‐Darmach
Edyta Gendaszewska‐Darmach
KBKatarzyna M. Błażewska
Katarzyna M. Błażewska

5 May 2015 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
ŁJŁukasz Joachimiak
Łukasz Joachimiak
ŁJŁukasz Janczewski
Łukasz Janczewski
JCJarosław Ciekot
Jarosław Ciekot
JBJanusz Boratyński
Janusz Boratyński
KBKatarzyna M. Błażewska
Katarzyna M. Błażewska
Fourteen novel prodrug-like analogs of two highly ionic phosphonocarboxylate inhibitors of Rab geranylgeranyl transferase were synthesized and preliminary assessment of their chemical and enzymatic stability was evaluated in buffers (pH 6.5 and 7.4) and rat intestinal homogenate (pH 6.5). Both acidic groups in phosphonocarboxylates were subject to modification. Phosphonic acid was protected either as bis(acyloxyalkyl) ester or phosphonodiamidate derived from amino acids. The carboxylic acid group was either left unchanged or was studied as ethyl ester. The compounds exhibited favorable stability in physiologically relevant pH (t1/2 above 18 h), while in intestinal homogenate they showed a large variety of half-lives (from 5 minutes to over 150 hours). LC MS studies have shown that the main product of decomposition under studied conditions resulted from cleavage of one of the ester (for acyloxyalkyl analogs) or amide (for phosphonodiamidate) bonds with phosphorus.